Внекостная кальцификация у пациентов с хронической болезнью почек


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

Рассматриваются вопросы классификации, эпидемиологии, патофизиологии, диагностики и осложнений внекостной кальцификации при хронической болезни почек, а также основные стратегии ведения пациентов.

Полный текст

Доступ закрыт

Об авторах

Г. Волгина

1МГМСУ

Email: VolginaGV@mail.ru
доктор медицинских наук, профессор

Д. Селезнев

ООО «Амджен»

кандидат медицинских наук

О. Балкарова

Городская клиническая больница №24

Е. Ловчинский

Госпиталь ветеранов войн №2

Список литературы

  1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group // Kidney Int. - 2009; 76 (Suppl. 113): S1-S130.
  2. Russo D., Palmiero G., De Blasio A. et al. Coronary artery calcification in patients with CRF not undergoing dialysis // Am. J. Kidney Dis. - 2004; 44: 1024-30.
  3. Spiegel D., Raggi P., Mehta R. et al. Coronary artery calcifications in patients new to dialysis // Hemodial. Int. - 2004; 8: 265-72.
  4. Raggi P., Boulay A., Chasan-Taber S. et al. Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease // J. Am. Col.l Cardiol. - 2002; 39: 695-701.
  5. Kalpakian M., Mehrotra R. Vascular calcification and disordered mineral metabolism in dialysis patients // Semin Dial. - 2007; 20: 139-43.
  6. Ribeiro S., Ramos A., Brandao A. et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism // Nephrol. Dial. Transplant. - 1998; 13: 2037-40.
  7. Milas M., Weber C.J. Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism // Surgery. - 2004; 136: 1252-60.
  8. Virchow R. Kalk-Metastasen // Virchows Arch. Pathol. Anat.- 1855; 8: 103-113.
  9. Giachelli C. Vascular Calcification Mechanisms // J. Am. Soc. Nephrol. -2004; 15: 2959-64.
  10. London G., Guerin A., Marchais S. et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality // Nephrol. Dial. Transplant.- 2003; 18: 1731-40.
  11. Kendrick J., Chonchol M. The role of phosphorus in the development and progression of vascular calcification // Am. J. Kidney Dis. - 2011; 58: 826-34.
  12. Adeney K., Siscovick D., Ix J. et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD // JASN. - 2009; 20: 381-7.
  13. Coen G., Manni M., Mantella D. et al. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients? // Nephrol. Dial. Transplant. -2007; 22: 3262-7.
  14. Danziger J. Vitamin K-dependent proteins, warfarin, and vascular calcification // CJASN. -2008; 3:1504-10.
  15. Giachelli C. Vascular calcification mechanisms // J. Am. Soc. Nephrol. -2004; 15: 2959-64.
  16. de Francisco A., Kim D., Anker S. et al. An epidemiological study of hemodialysis patients based on the European Fresenius Medical Care hemodialysis network: results of the ARO study // Nephron. Clin. Pract. - 2011; 118: 143-54.
  17. US Renal Data System. USRDS 2011 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. - 2011.
  18. Taddei S., Nami R., Bruno R. et al. Hypertension, left ventricular hypertrophy and chronic kidney disease // Heart Fail. Rev. - 2011; 16: 615-20.
  19. McEniery C., McDonnell B., So A. et al. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals // Hypertension. - 2009; 53: 524-31.
  20. Raggi P., Bellasi A., Gamboa C. et al. All-cause Mortality in Hemodialysis Patients with Heart Valve Calcification // CJASN. - 2011; 6: 1990-5.
  21. Schlieper G., Kruger T. Djuric Z. et al. Vascular access calcification predicts mortality in hemodialysis patients // Kidney International. - 2008; 74: 1582-7.
  22. Verbeke M. et al. Prognostic Value of Aortic Stiffness and Calcification for Cardiovascular Events and Mortality in Dialysis Patients: Outcome of the Calcification Outcome in Renal Disease (CORD) Study // CJASN. - 2010; 1 (7): 153-9.
  23. Goldsmith D. et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement // Nephrol. Dial. Transplant. - 2010; 25: 3823-31.
  24. Russo D., Miranda I., Ruocco C. et al. The Progression of Coronary Artery Calcification in Predialysis Patients on Calcium Carbonate or Sevelamer // Kidney Int. - 2007; 72 (10): 1255-61.
  25. Phan O., Ivanovski O., Nguyen-Khoa T. et al. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice // Circulation. - 2005; 112: 2875-82.
  26. Raggi P., Chertow G., Urena Torres P. et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients with hemodialysis // Nephrol. Dial. Transplant. -2010; 26(4): 1327-39.
  27. Regidor M. Cinacalcet reduces vascular and soft tissue calcification in secondary hyperparathyroidism (SHPT) in hemodialysis patients // Clin. Nephrol. -2009; 71 (2): 207-13.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ИД "Русский врач", 2012